「by」の検索結果
76件：11～15件目を表示
-
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
orado, United States of America Motugivatrep suppresses the expression of proinflammatory mediators by inhibiting TRPV1 activation mediated by hyperosmotic and inflammatory stimuli in human corneal ep...
https://www.senju.co.jp/english/rd/society/ -
临床试验信息 | 研究与开发 | 千寿制药株式会社
Completed jRCT2031210280 Disclaimer This website provides information on clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as “SENJU”) to the public including patie...
https://www.senju.co.jp/chinese/rd/trial.html -
ical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of software for dry-eye analysis in Japan as an option of RE...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906_0.pdf -
Management Policy | About Senju | SENJU Pharmaceutical
vision, and ideal employee image) into a concept called the "Senju Sense" that is shared by all Senju employees in the organization. To enhance unity and understanding among our employees, ...
http://www.senju.co.jp/english/about/philosophy.html -
eutical Co., Ltd. Launch and Distribution of “MIEr for ImageFS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of “MIEr for ImageFS” in Japan. MIEr for ImageFS...
https://www.senju.co.jp/system/files/content_news/2024-11/ENG_20241126.pdf